ZEALAND PHARMA A S's ticker is ZEAL and the CUSIP is 98920Y304. A total of 15 filers reported holding ZEALAND PHARMA A S in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $359,000 | -5.5% | 10,000 | 0.0% | 0.00% | -25.0% |
| Q3 2020 | $380,000 | +8.6% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $350,000 | +1.4% | 10,000 | 0.0% | 0.00% | -20.0% |
| Q1 2020 | $345,000 | +3.9% | 10,000 | 0.0% | 0.01% | +66.7% |
| Q4 2019 | $332,000 | +30.7% | 10,000 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $254,000 | +17.6% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $216,000 | +27.1% | 10,000 | 0.0% | 0.00% | +100.0% |
| Q1 2019 | $170,000 | +46.6% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $116,000 | -29.7% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $165,000 | +29.9% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $127,000 | -15.3% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $150,000 | +10.3% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $136,000 | -88.2% | 10,000 | -83.3% | 0.00% | -87.5% |
| Q3 2017 | $1,152,000 | – | 60,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 510,000 | $18,329,000 | 0.11% |
| AWM Investment Company, Inc. | 19,981 | $718,000 | 0.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 5,653 | $203,000 | 0.06% |
| WELLINGTON MANAGEMENT GROUP LLP | 1,099,546 | $39,517,000 | 0.01% |
| ROYCE & ASSOCIATES LP | 10,000 | $359,000 | 0.00% |
| Winslow, Evans & Crocker, Inc. | 235 | $8,000 | 0.00% |
| Renaissance Technologies | 17,205 | $618,000 | 0.00% |
| JANE STREET GROUP, LLC | 35,707 | $1,283,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Parallel Advisors, LLC | 94 | $3,000 | 0.00% |